Kelly Elise Dooley, M.D., Ph.D., M.P.H.

Biography

Dr. Dooley is a Professor of Medicine & Pharmacology at Johns Hopkins University with appointments in Clinical Pharmacology and Infectious Diseases. Her research focuses on tuberculosis therapeutics with an emphasis on clinical trials of TB drugs and HIV/TB co-treatment, as well as clinical pharmacology of TB and HIV drugs. She is a lead investigator for trials of therapeutics for drug-sensitive and drug-resistant TB, TB-HIV, and pediatric TB meningitis. She is on the TB scientific committees of the AIDS Clinical Trials Group and IMPAACT networks and is the Clinical Trials Site leader for JHU’s ACTG HIV trials unit.  She maintains an active HIV clinical practice. 

Invited lecture. Lessons learned for future TB drug development: a review of rifapentine
Topics
Position
Johns Hopkins University, United States